Mixtures of tense and relaxed state polymerized human hemoglobin regulate oxygen affinity and tissue construct oxygenation

Donald Andrew Belcher; Uddyalok Banerjee; Christopher Michael Baehr; Kristopher Emil Richardson; Pedro Cabrales; François Berthiaume; Andre Francis Palmer

doi:10.1371/journal.pone.0185988

Abstract

Pure tense (T) and relaxed (R) quaternary state polymerized human hemoglobins (PolyhHbs) were synthesized and their biophysical properties characterized, along with mixtures of T- and R-state PolyhHbs. It was observed that the oxygen affinity of PolyhHb mixtures varied linearly with T-state mole fraction. Computational analysis of PolyhHb facilitated oxygenation of a single fiber in a hepatic hollow fiber (HF) bioreactor was performed to evaluate the oxygenation potential of T- and R-state PolyhHb mixtures. PolyhHb mixtures with T-state mole fractions greater than 50% resulted in hypoxic and hyperoxic zones occupying less than 5% of the total extra capillary space (ECS). Under these conditions, the ratio of the pericentral volume to the perivenous volume in the ECS doubled as the T-state mole fraction increased from 50 to 100%. These results show the effect of varying the T/R-state PolyhHb mole fraction on oxygenation of tissue-engineered constructs and their potential to oxygenate tissues.

Citation: Belcher DA, Banerjee U, Baehr CM, Richardson KE, Cabrales P, Berthiaume F, et al. (2017) Mixtures of tense and relaxed state polymerized human hemoglobin regulate oxygen affinity and tissue construct oxygenation. PLoS ONE 12(10): e0185988. https://doi.org/10.1371/journal.pone.0185988

Editor: Alessandro Giuffrè, National Research Council, ITALY

Received: May 2, 2017; Accepted: September 23, 2017; Published: October 11, 2017

Copyright: © 2017 Belcher et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: This work was supported by National Institutes of Health grant R56HL123015, R01HL126945, and R01EB021926 to AFP (https://www.nih.gov/).

Competing interests: The authors have declared that no competing interests exist.

Introduction

A major challenge in tissue engineering is provision of physiologically relevant oxygenation to cells cultured within tissue-engineered constructs [1]. Perfusion/static culture solutions without an O₂ carrier cannot adequately oxygenate tissue-engineered constructs without the presence of significant hypoxic or hyperoxic regions [2]. A suitable alternative may consist of red blood cell (RBC) perfusion of the tissue culture in order to improve tissue oxygenation. Unfortunately, RBC perfusion may be plagued with issues ranging from short ex vivo storage shelf-life (i.e. 42 days) [3], limited supply [4,5], risk of transmission of unidentified pathogens [6], and RBC hemolysis [7]. In light of these challenges, hemoglobin (Hb)-based oxygen (O₂) carriers (HBOCs) have emerged as promising candidates for use as universal RBC substitutes in tissue engineering applications [8–13].

Our group has synthesized variable molecular weight (MW) HBOCs with low and high O₂ affinities [14–18] for use as RBC substitutes. These materials are based on glutaraldehyde polymerization of Hb in either the low O₂ affinity (i.e. tense (T)) or high O₂ affinity (i.e. relaxed (R)) quaternary state. In these studies, the T- or R-state PolyHbs either have low or high O₂ affinity, however many applications exist where it may be desirable to tune the O₂ affinity of the PolyHb solution to facilitate targeted O₂ delivery based on varying oxygenation requirements of tissues.

The current study expands upon the work of Zhang et al. [17] and Zhou et al. [18], who synthesized and characterized the biophysical properties of bovine and human PolyHbs in either T- or R-state. In this study, pure T- and R-state polymerized human Hb (PolyhHb) solutions were synthesized, characterized and mixed at different molar ratios to yield PolyhHb mixtures with varying O₂ affinities and biophysical properties. To assess the ability of the PolyhHb mixtures to oxygenate tissue engineered constructs, we developed a computational model of a single hollow fiber (HF) in a HF bioreactor housing hepatocytes (i.e. bio-artificial liver assist device), where the inlet partial pressure of O₂ (pO₂), mixture fraction, and total PolyhHb concentration were varied to assess oxygenation within the device. In vivo, the O₂ tension gradient sensed by hepatocytes is thought to play an important role in the establishment of functional zonation along the acinus, which is integral to the proper functioning of the liver [19]. HF bioreactors mimic the microenvironment of a blood vessel via the continuously circulating media in the HF lumen that transports nutrients and O₂ to the cells, while washing away metabolic waste products from the cells housed in the ECS. Therefore, this mathematical model can be used to assess the oxygenation potential of mixtures of T- and R-state PolyhHbs in tissue engineered constructs.

Materials and methods

Materials

Glutaraldehyde (50–70%), NaCl (sodium chloride), KCl (potassium chloride), NaOH (sodium hydroxide), Na₂S₂O₄ (sodium dithionite), CaCl₂.2H₂O (calcium chloride), sodium lactate, N-acetyl-L-cysteine (NALC), NaCNBH₃ (sodium cyanoborohydride), NaBH₄ (sodium borohydride), Na₂HPO₄ (sodium phosphate dibasic), and NaH₂PO₄ (sodium phosphate monobasic) were procured from Sigma-Aldrich (St. Louis, MO). The HF tangential flow filtration (TFF) modules (rated pore sizes: 0.2 μm, 50 nm, 500 kDa, and 100 kDa) were purchased from Spectrum Laboratories (Rancho Dominguez, CA). K₃FeCN₆ (potassium ferricyanide), KCN (potassium cyanide) and all other chemicals were purchased from Fisher Scientific (Pittsburgh, PA). Expired human RBC units were generously donated by Transfusion Services, Wexner Medical Center, The Ohio State University, Columbus, Ohio.

Hb purification

Human Hb (hHb) was purified via TFF as described by Palmer et al. [20].

Synthesis of PolyhHb

Deoxygenated and oxygenated hHb were polymerized with glutaraldehyde using methods developed previously [16,17] to yield 35:1 (molar ratio of glutaraldehyde to hHb) tense (T) and 30:1 relaxed (R) state PolyhHb, respectively.

To prepare 35:1 (molar ratio of glutaraldehyde to hHb) T-state (deoxygenated) PolyhHb, the hHb solution is devoid of dissolved O₂ prior to and during the polymerization reaction. Presence of minute quantities of dissolved O₂ will lead to formation of PolyhHb that is not exclusively in the T-state. To synthesize 30:1 R-state (oxygenated) PolyhHb, the Hb solution is fully saturated with O₂ prior to and after the polymerization reaction to yield PolyhHb molecules exclusively in the R-state.

To generate completely deoxygenated hHb, 30–33 g freshly thawed hHb was diluted in PBS (0.1 M, pH 7.4) at room temperature in a total volume of 1200 mL. The diluted hHb solution was placed inside a sealed, air-tight glass bottle under continuous stirring. The glass bottle was placed in a water-bath to maintain the temperature of the hHb solution at 37°C. Long stainless steel needles were used to de-gas the hHb solution by alternate cycles of charging the headspace with N₂ gas, and bubbling N₂ through the hHb solution. After 35–45 min of degassing, samples were drawn from the bottle using a long stainless steel needle to measure the pO₂ of the hHb solution using a Rapidlab 248 (Siemens, Malvern, PA) blood gas analyzer. When the measured pO₂ of the hHb solution dropped to < 20 mm Hg, Na₂S₂O₄ was added to the reaction vessel to remove residual O₂ from the hHb solution [17]. 300 mg Na₂S₂O₄ was dissolved in 300 mL N₂ sparged PBS (0.1 M, pH 7.4) at room temperature, the Na₂S₂O₄ solution was added to the hHb solution dropwise using a pump set to a flowrate of 0.1 mL/s. To confirm complete deoxygenation, the pO₂ of the hHb solution was measured at the end of the titration process. Once the pO₂ was out of range (pO₂ < 0 mm Hg), an additional 200 mg Na₂S₂O₄ was added to the hHb solution in 50 mg increments dissolved in 1 mL N₂ sparged PBS in 5 minute intervals using a syringe.

Completely deoxygenated hHb was then polymerized using a 35:1 molar ratio of glutaraldehyde to hHb. The glutaraldehyde solution was prepared by diluting the necessary volume of glutaraldehyde with 5–10 mL of degassed PBS (0.1 M, pH 7.4). A 10 mL syringe was used to add the glutaraldehyde solution dropwise to the deoxygenated hHb under continuous stirring. The polymerization reaction was allowed to proceed at 37°C for 2 h in the absence of light under a N₂ atmosphere.

R-state hHb was prepared by saturating 1500 mL of a 20 mg/mL hHb solution with pure O₂ gas for a period of 1–1.5 h at 37°C. Long stainless steel needles were used to oxygenate the hHb solution with alternate cycles of charging the headspace with O₂ gas and bubbling O₂ through the hHb solution. Complete O₂-saturation of hHb solution was confirmed by measuring the pO₂ of the hHb solution (pO₂ > 749 mm Hg) [17]. Oxygenated hHb was then polymerized at a 30:1 molar ratio of glutaraldehyde to hHb. The glutaraldehyde solution was prepared by diluting the necessary volume of glutaraldehyde with 5–10 mL of oxygenated PBS (0.1 M, pH 7.4). A 10 mL syringe was used to add the glutaraldehyde solution dropwise to oxygenated hHb under continuous stirring. The polymerization reaction was allowed to proceed at 37°C for 2 h in the absence of light under an O₂ atmosphere [17]. A schematic of the reactor setup used is shown in Fig 1.

Download:

Fig 1. Schematic of the PolyhHb reactor vessel.

This figure shows the glass bottle bench scale polymerization reactor used in our process to synthesize both the tense and relaxed state PolyhHb.

https://doi.org/10.1371/journal.pone.0185988.g001

To reduce the resultant Schiff bases and the methemoglobin (metHb) level of the PolyhHb solution, 6–8 mL of 6–8 M NaCNBH₃ in PBS (0.1 M, pH 7.4) was added to the reaction vessel at the end of the reaction. The PolyhHb reaction vessel was placed in an ice-bath under continuous stirring for 30 min. Finally, 15–20 mL of freshly made 2 M NaBH₄ was injected into the reaction vessel to reduce unreacted aldehydes. NaBH₄ and NaCNBH₃ were used in conjunction, since they reduce Schiff bases and free aldehyde in solution [16,17,21]. The pO₂ of the hHb solution was monitored before and after polymerization to ensure that the polymerization reaction was carried out with hHb in the desired quaternary state (T- or R-state).

Diafiltration of PolyhHb

Small hHb polymers, reduced glutaraldehyde, and excess quenching reagents were removed from the synthesized PolyhHb solutions using a diafiltration protocol developed in our lab. PolyhHb solutions were passed through 0.2 μm TFF modules to remove large particles. PolyhHb solutions were then buffer exchanged in an isotonic modified Ringer’s lactate buffer (NaCl 115 mmol/L, KCl 4 mmol/L, CaCl₂.2H₂O 1.4 mmol/L, NaOH 13 mmol/L, sodium lactate 27 mmol/L, and NALC 12.3 mmol/L). The PolyhHb solutions were subjected to 8–9 cycles of diafiltration (4°C) on 500 kDa TFF modules at a 1:9 (v/v) ratio of PolyhHb to modified Ringer’s lactate buffer. Fig 2 shows a schematic of the diafiltration setup used in the study. This process was performed at 4°C under ambient air conditions.

Download:

Fig 2. Diafiltration, purification, and concentration schematic.

Shown in this figure is the multistage tangential flow filtration process for processing the polymerized PolyhHb.

https://doi.org/10.1371/journal.pone.0185988.g002

The filtrate from the 9^th diafiltration cycle was collected and measured via UV-visible spectroscopy to verify complete removal of small hHb species. Buffer-exchanged PolyhHb solutions were concentrated on 500 kDa TFF cartridges (Spectrum Labs, Rancho Dominguez, CA). The resulting concentrated PolyhHb solutions were stored at -80°C. Sterile lab supplies were used for all experiments. All tubing, glassware, and filters were de-contaminated by immersing them overnight in 1 M NaOH and then rinsing thoroughly with double distilled de-ionized water.

Preparation of T- and R-State PolyhHb mixtures

Stock solutions of 35:1 T-state PolyhHb and 30:1 R-state PolyhHb having the same molar concentration (on a heme basis) were prepared. These stock solutions were mixed at different molar ratios i.e. 0.25:0.75, 0.5:0.5, and 0.75:0.25 to yield mixtures of T- and R-state PolyhHbs.

Hydrodynamic diameter of PolyhHb

The hydrodynamic diameter of PolyhHb was measured using a Zetasizer Nano Dynamic Light Scattering (DLS) spectrometer (Malvern Instruments Ltd., Worcestershire, United Kingdom) at 37°C [21]. The PolyhHb solutions were diluted to a final concentration of ~ 2 mg/mL using PBS (0.1 M, pH 7.4). An internal heating system and temperature controller maintained the sample temperature at 37°C [21].

Methemoglobin level and protein concentration of hHb/PolyhHb

The cyanomethemoglobin method was used to measure the methemoglobin (metHb) level of hHb/PolyhHb solutions [22,23]. The Bradford assay was performed using the Coomassie Plus protein assay kit (Pierce Biotechnology, Rockford, IL) to estimate the total protein concentration in solution [17,24].

O₂–hHb/PolyhHb equilibria measurements

O₂-hHb/PolyhHb equilibrium binding curves were generated using a Hemox Analyzer (TCS Scientific Corp., New Hope, PA) at 37°C (physiological temperature) as described in the literature. The Hill equation (Eq 1) was used to fit the OEC obtained for hHb/PolyhHb [22,25]. (1) Where Abs is the measured absorbance of the sample, A₀ and A_∞ correspond to the sample absorbance at 0 mm Hg and at maximum saturation, respectively. The P₅₀ (partial pressure of O₂ at which 50% of the hHb/PolyhHb is saturated with O₂) and the cooperative coefficient (n) of hHb/PolyhHb were regressed by fitting the OECs to Eq 1 [25].

Rapid kinetic measurements of hHb/PolyhHb solutions

hHb/PolyhHb gaseous ligand binding/release kinetics were measured using an Applied Photophysics SF-17 microvolume stopped-flow spectrophotometer (Applied Photophysics Ltd., Surrey, United Kingdom). Rapid kinetic measurements were performed using protocols previously described by Rameez and Palmer [10,11,26]. For all stopped-flow measurements, a control of hHb was used to ensure the authenticity of the results. PBS (0.1 M, pH 7.4) was used as the reaction buffer for all kinetic measurements. Flash photolysis mediated O₂ association kinetics were measured using procedures described by Olsen et al. [27]. Prior to flash photolysis, each sample was oxygenated by placing it under 1 atm of O₂ for 15 minutes. Complete oxygenation was verified by spectral analysis. Flash photolysis was performed on 12.75 μM (on a per heme basis) samples with an excitation wavelength of 425 nm (3.5 mJ/pulse). Samples were excited with a Q-switch Nd-YAG laser (Spectra Physics, Santa Clara, CA) pumped optical parametric oscillator (Spectra Physics, Santa Clara, CA) that delivered pulses of ca. 8 ns at 10 Hz. The pulse energy was about 3.5 mJ/pulse at the sample. The spectrometer (Edinburgh Instruments LP980, Livingston, UK) used a 150 W Xe-lamp to generate probe light at a 90 degree angle from the pump laser. Kinetic traces were recorded by PMT and a digital oscilloscope, while transient spectra were collected with a CCD (Andor Technology, Belfast, UK). O₂ association was monitored at 430 nm. Complete photolysis of O₂ was verified for each sample.

Computational methods

To assess the ability of mixtures and T- and R-state PolyhHb to oxygenate tissue engineered constructs, we computationally evaluated O₂ transport in a single fiber of a HF bioreactor housing hepatocytes (i.e. bio-artificial liver assist device). This type of device can be used to replicate various liver functions, and has been used as an artificial liver assist device to support patients with failing livers [28]. The HF bioreactor modeled in this study consists of a Spectrum Laboratories (Rancho Dominguez, CA) commercial HF bioreactor (cat.#400–011) containing 2,205 individual polyethylene fibers. The HF membrane has a 35 kDa MW cut-off which prevents PolyhHb (M_w > 35 kDa) transport out of the lumen into the extra capillary space (ECS). The ECS houses cultured hepatocytes. The O₂ concentration profile was modeled with a modified form of the Krogh tissue cylinder model. This model consists of three subdomains: a cylinder representing the lumen, an annulus representing the membrane, and an outer annulus representing the ECS. A mixture of cell culture media and PolyhHb flows through the lumen to provide nutrients and remove waste to/from the cells which reside entirely within the ECS. A schematic of the HF bioreactor system and individual HF model geometry is shown in Fig 3.

Download:

Fig 3. Schematic of the HF bioreactor system and individual HF model geometry.

Shown here is the basic schematic of hemoglobin solutions pumped through a HF reactor with uniformly distributed fibers with the shown geometry.

https://doi.org/10.1371/journal.pone.0185988.g003

Additional information about this model and the physical constants used can be found in the literature [29]. The model is evaluated with finite element analysis in Comsol Multiphysics (Version 4.3, Comsol, Inc., Burlington, MA). Pressure and velocity profiles were first evaluated independently. Mass conservation equations for O₂, and the HBOCs were then solved simultaneously. Inlet pO₂, total HBOC concentration, and HBOC fraction were varied during simulation by 0–140 mm Hg, 0–130 mg/mL and 1–100% R-state respectively.

Results and discussion

PolyhHb synthesis and characterization

It is necessary to measure the biophysical properties of 35:1 T-state PolyhHb, 30:1 R-state PolyhHb, and various mixtures of these two types of HBOCs to evaluate their O₂ transport potential in transfusion and tissue engineering applications. Table 1 compares the biophysical properties (hydrodynamic diameter, protein concentration, % metHb, O₂ equilibria, and gaseous ligand binding/release kinetics) of hHb, 35:1 T-state PolyhHb and 30:1 R-state PolyhHb. Table 1 also compares the biophysical properties of molar mixtures of 35:1 T-state PolyhHb and 30:1 R-state PolyhHb. In this comparison, one batch of 35:1 T-state PolyhHb and one batch of 30:1 R-state PolyhHb were selected to formulate the mixtures. Therefore, entries in Table 1 do not have error bars.

Download:

Table 1. Biophysical properties of PolyhHb.

https://doi.org/10.1371/journal.pone.0185988.t001

Hydrodynamic diameter of PolyhHb

The hydrodynamic diameter of 35:1 T-state PolyhHb (93.78 ± 16.34 nm) was not significantly different (p<0.05) compared to the diameter of 30:1 R-state PolyhHb (87.17 ± 12.72 nm). However, the measured particle diameter for mixtures of T- and R-state PolyhHbs was proportional to the molar ratio of pure T-state and pure R-state PolyhHb. In contrast, the diameter of T- and R-state PolyhHbs was significantly (p<0.05) larger than the diameter reported in the literature for cell-free hHb (~5.5 nm) [30]. Therefore, the large molecular radius of T- and R-state PolyhHbs can avoid the side-effects associated with transfusion of cell-free Hb such as unfolding of the globin chain leading to the release of cytotoxic free-heme and renal toxicity, dissociation of tetrameric Hb into αβ dimers and extravasation through the blood vessel wall into the surrounding tissue space leading to oxidative tissue injury, and scavenging of endothelial NO leading to vasoconstriction and systemic hypertension [10,11,31–33].

MetHb level and protein concentration of PolyhHb

The metHb level of 35:1 T-state PolyhHb was significantly (p<0.05) higher than 30:1 R-state PolyhHb (Table 1). However, metHb levels for the mixtures showed no trend with mixture ratio. R-state PolyhHb was synthesized in an oxygenated environment, and intuitively expected to yield higher metHb levels compared to T-state PolyhHb. However, the opposite was observed. This can be explained by the duration of hHb deoxygenation before polymerization. For R-state PolyhHb, the polymerization reaction is initiated after 1–1.5 h of oxygenation while in T-state it is 2 hours after deoxygentation. The extended period of time hHb is maintained at 37°C during the deoxygenation step leads to higher metHb levels for T-state PolyhHb.

Protein concentrations for 35:1 T-state and R-state PolyhHb solutions ranged between 11.04 ± 1.13 and 11.72 ± 1.44 g/dL, respectively. These concentrations are comparable to the Hb concentration in whole blood (15.7 g/dL for men and 13.8 g/dL for women) [34]. Additionally, these concentrations are comparable to the Hb concentrations reported in the literature for commercial HBOCs: HBOC-201^® ([Hb] ~ 13 g/dL), PolyHeme^® ([Hb] ~ 10 g/dL) [35], and Hemolink^® ([Hb] ~ 9.7 g/dL) [36].

O₂–hHb/PolyhHb equilibria

The O₂-hHb/PolyhHb equilibrium data were fit to the Hill equation (Eq 1) to regress the P₅₀ and cooperativity coefficient (n). Unlike hHb, the shape of the equilibrium O₂ binding curves obtained for PolyhHbs are not sigmoidal. This indicates a significant loss in cooperative binding of O₂ to Hb in PolyhHbs compared to unmodified hHb. These observations are shown in Fig 4(A), which compares typical O₂ equilibrium curves of hHb, 30:1 R-state PolyhHb, 35:1 T-state PolyhHb, and mixtures of 35:1 T-state PolyhHb and 30:1 R-state PolyhHb at molar ratios of 0.75:0.25, 0.50:0.50 and 0.25:0.75. Dots represent experimental data and corresponding solid lines of the same color represent curve fits.

Download:

Fig 4. hHb and PolyhHb O₂ equilibrium.

(A) Comparison of O₂ equilibrium curves of hHb, 30:1 R-state PolyhHb, 35:1 T-state PolyhHb, and mixtures of 35:1 T-state PolyhHb and 30:1 R-state PolyhHb at various molar fractions of T: 0.75,0.5 and 0.25. Dots represent experimental data and the corresponding solid lines of the same color represent curve fits. (B) Dependence of P₅₀ on mole fraction of 35:1 T-state PolyhHb to 30:1 R-state PolyhHb. The data were fit to a linear function using JMP 9.2.

https://doi.org/10.1371/journal.pone.0185988.g004

The 35:1 T-state PolyhHb exhibited lower O₂ affinity (P₅₀ ~ 37.35 ± 7.91 mm Hg) compared to hHb (P₅₀ ~ 12.40 ± 1.04 mm Hg). Polymerization of Hb in the deoxy-state limits the resultant PolyhHb to the T-state quaternary conformation compared to native Hb, thereby accounting for its higher P₅₀ [17,37]. In contrast, high O₂ affinity (P₅₀ ~ 1.96 ± 0.77 mm Hg) was observed for 30:1 R-state PolyhHb compared to hHb and T-state PolyhHb. Polymerization of Hb in the oxygenated-state limits the resultant PolyhHb to the R-state quaternary conformation thereby accounting for its’ lower P_50s [17]. The literature suggests that HBOCs with high P_50s target O₂ transport to the systemic circulation, while HBOCs with low P_50s target O₂ transport to the peripheral tissues via microcirculation [37]. Furthermore, mixtures of HBOCs with varying O₂ affinities might be a suitable option for restoring tissue oxygenation during resuscitation from hemorrhagic shock [15]. Therefore in this study, we evaluated in silico the ability of mixtures of 35:1 T-state PolyhHb and 30:1 R-state PolyhHb at molar ratios of 0.75:0.25, 0.50:0.50, and 0.25:0.75 to supply and regulate O₂ levels in a single fiber of a HF hepatic bioreactor. We observed that the P₅₀ for various mixtures of T- and R-state PolyhHbs were proportional to the molar ratio of pure T-state and pure R-state PolyhHb (Table 1). Fig 4(B) shows the dependence of P₅₀ on molar ratio of 35:1 T-state to 30:1 R-state PolyhHbs. These data were fit to a linear function using JMP 9.2.

Both 35:1 T-state and 30:1 R-state PolyhHbs display lower cooperativity (n) compared to unmodified hHb (n ~ 2.62 ± 0.10) (Table 1). The quaternary conformational changes observed in a Hb molecule during its transition from the deoxy- to the oxy-state involve rotation of the two symmetrical αβ dimers by 15° relative to each other and a translation of 0.1 nm along the rotation axis [38]. This rotation about the axis is perhaps hindered by the inter- and intra-molecular glutaraldehyde cross-links in PolyhHb molecules, thus resulting in the observed low cooperativities [21].

Rapid kinetic measurements of hHb/PolyhHb solutions

The kinetics of PolyhHbs with physiological relevant gaseous ligands were measured to compare their ligand binding/release kinetics. These rates are important to evaluate the ability of these particles to store and transport important gaseous ligands such as O₂, CO, and NO. NO dioxygenation kinetics can predict the ability of PolyhHb to scavenge NO, which is the major mechanism for the development of vasoconstriction and systemic hypertension. O₂ dissociation measurements can be linked to autoregulation theory for the development of vasoconstriction and systemic hypertension [10].

Reactions with O₂

for 35:1 T-state PolyhHb (47.35 ± 4.15 s^-1) was significantly (p<0.05) higher than that obtained for 30:1 R-state PolyhHb (23.98 ± 4.11 s^-1) and unmodified hHb (37.06 ± 2.92 s^-1). Also, values obtained for R-state PolyhHb are significantly lower (p<0.05) than the rate constant obtained for unmodified hHb. Furthermore, we observed that for various mixtures of T- and R-state PolyhHbs increased with increasing molar ratio of 35:1 T-state to 30:1 R-state PolyhHb (Table 1). These observations are consistent with the literature and are expected given the contrasting O₂ affinities of T- and R-state PolyhHbs [15,17]. for 35:1 T-state PolyhHb (12.12 ± 0.69 s^-1μM^-1) was significantly (p<0.05) lower than that obtained for 30:1 R-state PolyhHb (28.59 ± 0.66 s^-1μM^-1) and unmodified hHb (40.85 ± 1.49 s^-1μM^-1). In addition, values obtained for 30:1 R-state PolyhHb are significantly (p<0.05) lower than that obtained for unmodified hHb. In these flash photolysis experiments, we observed that the rate of O₂ binding to T-state PolyhHb was significantly lower than unmodified hHb. This can be explained by incomplete O₂ binding to T-state PolyhHb even under 1 atm of pure O₂. At equilibrium and at this dissolved O₂ concentration (pO₂ ~740 mm Hg), 35:1 T-state PolyhHb is only ~95% saturated with O₂. However, for unmodified hHb was similar to reported literature values [39,40]. Interestingly, for 35:1 T-state PolyhHb was on the same order of magnitude compared to chemically modified T-state hHb (5–10 s^-1μM^-1) [27]. However, for 35:1 T-state PolyhHb was drastically different compared to chemically modified T-state hHb (~500–1000 s^-1) [27]. For 30:1 R-state PolyhHb, was similar to the values reported for R-state hHb (~20 s^-1) [27]. In contrast, the value for for 35:1 R-state PolyhHb was dramatically different compared to R-state hHb (~66 s^-1μM^-1) [27]. Reduced interactions between neighboring globin subunits in T- and R-state PolyhHb compared to non-polymeric R- and T-state hHb may result in the observed deviations for PolyhHb O₂ association and dissociation kinetics when the PolyhHb is not in the thermodynamically preferred conformational state (i.e. fully deoxygenated T-state PolyhHb or fully oxygenated R-state PolyhHb). Unfortunately, the random and extensive nature of the glutaraldehyde crosslinks precludes any higher-level analysis of this behavior. Similar effects are further demonstrated in the reduced NO dioxygenation reaction rate constant for the PolyhHbs compared to hHb. Fig 5 compares typical kinetic time courses of O₂ dissociation and association for hHb, 35:1 T-state PolyhHb and 30:1 R-state PolyhHb.

Download:

Fig 5. Deoxygenation and oxygenation kinetic time courses for hHb, T-state PolyhHb and R-state PolyhHb.

(A) Comparison of time courses for deoxygenation in the presence of 1.5 mg/mL sodium and (B) oxygenation time course facilitated by flash photolysis of hHb (red), 30:1 R-state PolyhHb (black), and 35:1 T-state PolyhHb (blue). Dots represent experimental data and the corresponding solid lines of the same color represent curve fits. The experimental data shows an average of 10–15 kinetic traces. For deoxygenation, the reactions were monitored at 437.5 nm and 20°C. For oxygenation, the reactions were monitored at 430 nm. PBS (0.1 M, pH 7.4) was used as the reaction buffer.

https://doi.org/10.1371/journal.pone.0185988.g005

The high O₂ offloading rate of cell-free hHb forms the basis of autoregulation theory that explains the development of vasoconstriction and systemic hypertension upon transfusion of HBOCs [41–43]. Thus, moderate O₂ release rates are critical in improving HBOC efficacy. Therefore, the PolyhHbs and their mixtures synthesized in our lab can potentially deliver O₂ to ischemic tissues at regulated rates potentially avoiding vasoconstriction resulting from the oversupply of O₂.

Reactions with CO

Fig 6 shows characteristic CO association kinetic time courses for deoxygenated hHb (A), 30:1 R-state PolyhHb (B), and 35:1 T-state PolyhHb (C). The dependence of the pseudo first-order rates on CO concentration for hHb, 35:1 T-state PolyhHb, and 30:1 R-state PolyhHb is shown in panel D. Therefore, the slopes of the linear fits in panel D indicate the second-order CO association rate constants reported in Table 1.

Download:

Fig 6. Time courses for the CO association reaction.

Time courses for the CO association reaction with deoxygenated (A) hHb, (B) 30:1 R-state PolyhHb, and (C) 35:1 T-state PolyhHb. Dots represent experimental data and the corresponding solid lines of the same color represent curve fits. Experimental data shows an average of 10–15 kinetic traces. The reactions were monitored at 437.5 nm and 20°C. PBS (0.1 M, pH 7.4) was used as the reaction buffer. (D) Comparison of CO association rates of hHb, 35:1 T-state PolyhHb, and 30:1 R-state PolyhHb. The error bars represent the standard deviation from 15 replicates.

https://doi.org/10.1371/journal.pone.0185988.g006

The k_on,_CO rates obtained for unmodified hHb and 30:1 R-state PolyhHb evaluated in this study are significantly higher (p<0.05) than the values obtained for 35:1 T-state PolyhHb (Table 1). Similar findings have been reported in the literature and suggest that polymerization of Hb in the T-state limits heme pocket accessibility to CO [15]. Moreover, polymerization of Hb in the R-state results in more open conformation and greater heme pocket accessibility. This explains the higher k_on,_CO rate constant observed for 30:1 R-state PolyhHb [15]. The k_on,_CO rate constants for the T- and R-state molar mixtures showed no trend with mixture ratio (Table 1).

Reactions with NO

Fig 7 shows characteristic NO dioxygenation kinetic time courses for oxygenated hHb (A), 30:1 R-state PolyhHb (B), and 35:1 T-state PolyhHb (C). The dependence of the pseudo first-order rates on NO concentration for hHb, 35:1 T-state PolyhHb, and 30:1 R-state PolyhHb is shown in panel D. Therefore, the slopes of the linear fits in panel D are used to calculate the second-order NO dioxygenation rate constants reported in Table 1. The NO dioxygenation rate constant for 35:1 T-state PolyhHb was comparable (p>0.05) to the rate constant for 30:1 R-state PolyhHbs (Table 1). Similar k_oX,_NO values have been reported in the literature [15,17]. The k_oX,_NO for molar mixtures of T- and R-state PolyhHb showed no trend with mixture ratio.

Download:

Fig 7. Time courses for the NO deoxygenation reaction.

Time courses for the NO dioxygenation reaction with oxygenated (A) hHb, (B) 30:1 R-state PolyhHb, and (C) 35:1 T-state PolyhHb. Dots represent experimental data and the corresponding solid lines of the same color represent curve fits. Experimental data shows an average of 7–10 kinetic traces. The reactions were monitored at 420 nm and 20°C. PBS (0.1 M, pH 7.4) was used as the reaction buffer. (D) Comparison of NO dioxygenation rates of hHb, 35:1 T-state PolyhHb, and 30:1 R-state PolyhHb. The error bars represent the standard deviation from 15 replicates.

https://doi.org/10.1371/journal.pone.0185988.g007

Comparison to commercial HBOCS

Comparisons (wherever possible) were made between the biophysical properties of T- and R-state PolyhHbs synthesized in this study and commercial HBOCs. The biophysical properties of selected commercial HBOCs are shown in Table 2. The T- and R-state PolyhHbs synthesized in this study have significantly larger diameters compared to the computed diameters [44] of Oxyglobin^® (Biopure Corp, Cambridge, MA, USA) and Hemolink^® (Hemosol Inc., Toronto, Canada) [45,46]. MetHb values observed for the T- and R-state PolyhHbs synthesized in our lab are comparable to those reported for HBOC-201^®, PolyHeme^® (Northfield Laboratories Inc., Northfield, IL, USA) [35], and Hemolink^® [36]. The P_50s of 35:1 T-state PolyhHbs are in agreement with the P₅₀ values reported in the literature for commercial HBOCs, HBOC-201^®, PolyHeme^® [35], and Hemolink^®.The cooperativity values of the T- and R-state PolyhHbs are comparable to the reported values HBOC-201^® [35] and Hemolink^® [36]. The observed n values are slightly lower than those reported for PolyHeme^® [35]. The values for T- and R-state PolyhHbs are lower than the deoxygenation rate constants reported in the literature for Hemolink^® [47], and Oxyglobin^® [46]. The k_on,_CO values for T-state PolyhHbs are comparable to those reported in the literature for Hemolink^® [47], but are significantly lower than the values recorded for Oxyglobin^® [46]. In contrast, CO association rate constants for R-state PolyhHbs are comparable to Oxyglobin^®, but are significantly higher than Hemolink^®.

Download:

Table 2. Biophysical properties of commercially available HBOCs.

https://doi.org/10.1371/journal.pone.0185988.t002

Computational results

The measured biophysical properties of pure T- and R-state PolyhHb solutions (Table 1) were incorporated into a computational model describing O₂ transport in a single fiber of a hepatic HF bioreactor where the inlet pO₂, mixture fraction, and total PolyhHb concentration were varied.

Unsupplemented cell culture media was used as the control, while unmodified hHb was simulated for comparison. Unsupplemented cell culture media normalized O₂ flux through the HF membrane for selected molar ratios of T- and R-state PolyhHb and hHb as a function of inlet pO₂ is shown in Fig 8. For all HBOC molar ratios, the normalized O₂ flux decreased as the inlet pO₂ increased. At high pO_2,in (>80 mm Hg) the normalized O₂ flux was similar to a 25% T-state PolyhHb fraction. At pO_2,in values ranging from 5–40 mm Hg, the simulated normalized flux of unmodified hHb was greater than all HBOC mixtures.

Download:

Fig 8. Effects of PolyhHb mixtures and hHb on oxygenation of the HF bioreactor.

(A) Unsupplemented cell culture media (i.e. no HBOC) normalized O₂ flux through the HF membrane for various 35:1 T-state PolyhHb and 30:1 R-state PolyhHb mixtures compared to hHb at Q = 40 mL/min and [PolyhHb]_total = [hHb] = 130 mg/mL. (B) Pure R-state normalized O₂ consumption in the ECS versus PolyhHb T-state fraction, for various pO_2,ins, Q = 40 mL/min and [PolyhHb] = 130 mg/mL.

https://doi.org/10.1371/journal.pone.0185988.g008

Pure R-state normalized O₂ consumption by the hepatocytes housed in the ECS at various pO_2,ins as a function of T-state PolyhHb fraction is shown in Fig 8. Here O₂ consumption is used as an indicator of O₂ delivery to the cultured hepatocytes. For low pO_2,ins (<12 mm Hg), the rate of hepatocyte O₂ consumption is greatest for pure R-state PolyhHb. At pO_2,in values close to 12 mmHg, the molar ratio of T-state to R-state PolyhHb has a negligible effect on O₂ delivery. At increasing moderate pO_2,in values (12–40 mm Hg), O₂ delivery increases with increasing molar ratio of T-state to R-state PolyhHb. At increasing high pO_2,in values (>40 mm Hg), the effect of the T-state to R-state PolyhHb mixture ratio on O₂ consumption decreased.

Simulated pO₂ profiles for PolybHb mixtures and unmodified hHb supplemented cell culture media within the lumen, membrane, and ECS associated with a single HF are shown in Fig 9. The maximum protein concentration (130 mg/mL) was selected to approximate heme concentrations in vivo (i.e. in whole blood). Each frame in the figure represents a cross-sectional slice of a single HF unit. Flow in the system proceeds from left to right. The bottom of each panel corresponds to the HF centerline. In simulations with unsupplemented cell culture media, approximately 90% of the pO₂ in the ECS was below 20 mm Hg. Oxygenation of the ECS improves with increasing protein concentration and increasing fraction of PolybHb in the T-state. These simulations demonstrate that the pO₂ distributions for the 25% T-state PolybHb mixture are similar to that of unmodified hHb.

Download:

Fig 9. pO₂ distribution in a single hollow fiber.

Varying protein concentration was used for each species (y axis) for different hemoglobin species transfusion (x axis). The O₂ content is depicted by a color scale from 0 to 80 mm Hg. Q = 40 mL/min pO_2,in = 80 mm Hg.

https://doi.org/10.1371/journal.pone.0185988.g009

Zonal heterogeneity in the liver sinusoid, which stems from O₂ dependent regional variations in hepatocyte function, results in a “glucosat” in the liver [19,51]. This functionality is important in maintaining blood glucose levels during feeding and fasting periods. A variety of detoxification functions, which rely on sequential phase I and phase II metabolic enzymes, also requires proper zonation of these enzymes along the hepatic acinus [52]. Thus, replicating the zonation observed in the liver sinusoid is vital in bioartificial liver design. The ECS zonation plots for mixtures of PolybHb, unmodified hHb, and plain cell culture media at various pO_2,ins are shown in Fig 10. Oxygenation zones within the ECS are classified as follows [51]: hypoxic (<20 mm Hg), perivenous (20–30 mm Hg), pericentral (35–60 mm Hg), periportal (60–70 mm Hg), and hyperoxic (>70 mm Hg). For unsupplemented cell culture media, a small fraction (12%-25%) of the hepatocytes are exposed to normoxic pO₂ levels (20–70 mm Hg). For low pO_2,ins (40 mm Hg and 60 mm Hg), the majority of the hepatocytes are exposed to hypoxic conditions (>40%) regardless of T-/R-state PolyhHb molar fraction. At pO_2,in = 80 mm Hg, the fraction of hepatocytes exposed to normoxic conditions with R-state PolyhHb (43%) is much less than the fraction of hepatocytes with T-state PolyhHb (99.9%). For pO_2,in at 80 mm Hg, the hypoxic region remains less than 5% for T-state PolyhHb fractions greater than 50%. The ratio of hepatocytes in the pericentral region to those in the perivenous region increases from 0.91 to 1.85 as the T-state PolyhHb fraction increases from 50% to 100%. For pO_2,in = 100 mm Hg, a fraction of the hepatocytes (4–7%) are exposed to hyperoxic conditions.

Download:

Fig 10. ECS zonation for PolyhHb fractions, hHb, and unsupplemented (plain) media for various pO_2,ins.

This figure displays the zonation (hyperoxic, periportal, perivenous, hypoxic) for PolyhHb fractions, hHb, and unsupplemented (plain) media where the pO_2,in is equal to (A) 40 mm Hg, (B) 60 mm Hg, (C) 80 mm Hg, and (D) 100 mm Hg. For this simulation Q = 40 mL/min and [PolyhHb]_total = [hHb] = 130 mg/mL.

https://doi.org/10.1371/journal.pone.0185988.g010

At low pO_2,ins (<40 mm Hg), unmodified hHb was able to deliver more O₂ than the PolyhHbs synthesized in this study. This phenomenon likely results from the low cooperativity and high MW (i.e. lower diffusivity) of the synthesized PolyhHbs. For inlet pO₂ ranges similar to the inlet conditions in the liver sinusoid (>60 mmHg), T-state PolyhHb delivered more O₂ to the cells in the ECS. Furthermore, as the pO_2,in increased, the fraction of T-state PolyhHb required to outperform unmodified hHb decreased. This is likely due to the increased O₂ dissociation rate constant of T-state PolyhHb. At low pO_2,ins (<12 mmHg), the O₂ delivery of R-state PolyhHb outperformed T-state PolyhHb. This can be explained by an increase in O₂-offloading at low pO_2,ins for R-state PolyhHb. This indicates that R-state PolyhHbs may be better suited to oxygenate hypoxic areas. To explore these effects further, we examined how the volume fraction of the periportal, pericentral, and perivenous sections varied as a function of the pO_2,in for PolyhHb mixtures and unmodified Hb. We then excluded any simulation results where the sum of the hypoxic and hyperoxic fractions was less than 10% of the total volume in the ECS. The results of this analysis are shown in Fig 11. Overall, pure T-state PolyhHb had the largest operating range where minimal hypoxic/hyperoxic behavior was observed (70–95 mm Hg). Increasing the mole fraction of R-state PolyhHb lead to increasingly narrow operating ranges. For pure R-state PolyhHb, no region was observed where the sum of the hypoxic and hyperoxic volume fractions were less than 10%. Decreasing the mole fraction of R-state PolyhHb in the PolyhHb mixture lead to broadened operational ranges. Interestingly, unmodified hHb had a similar operating curve to R-state PolyhHb. However, both the high mole fraction R-state PolyhHb mixtures and unmodified hHb solutions had less variation in the volume fractions for each zone compared to the high mole fraction T-state PolyhHb mixtures.

Download:

Fig 11. ECS zonation at varying pO_2,ins for various PolyhHb mole fractions and pure hHb.

This figure displays the zonation fractions of (A) periportal, (B) pericentral, and (C) perivenous regions for various PolyhHb mixtures and pure hHb where the sum of the hypoxic and hyperoxic fractions are less than 10% of the total volume. For this simulation Q = 40 mL/min and [PolyhHb]_total = [hHb] = 130 mg/mL.

https://doi.org/10.1371/journal.pone.0185988.g011

As expected, T-state PolyhHb has the potential to oxygenate a HF bioreactor better than R-state PolyhHb and unmodified hHb. These results are in agreement with the simulations performed by Zhou et al. [18]. The results of the finite element analysis indicate that O₂ delivery can be controlled by adjusting the molar ratio of T-state to R-state PolyhHb in solution. When the T-state to R-state molar fraction drops below 50%, O₂ delivery rapidly decreases. Therefore, it is recommended that mixtures of PolyhHb contain no less than 50% T-state PolyhHb. The percent of R-state PolyhHb may be tuned to both vary zonation or to increase O₂ delivery to severely hypoxic regions. Finally, unmodified hHb may be favorable in maintaining relatively constant zonation if the pO_2,in varies. However, this provides much less flexibility in establishing different oxygenation zones due to the limited operating range of unmodified hHb. This is especially important considering the geometry of the hollow fiber bioreactor. In vivo, blood flows into the liver through both the portal and vein. This leads to an O₂ gradient and functional zonation between arterioles and the central veins [19]. Replicating this oxygen gradient in vitro would necessitate a more complex bioreactor design. However, the results from the simulations indicate that application of the PolyhHb mixtures can vary the zonation despite not exhibiting the cooperative O₂ binding behavior of native hHb.

Conclusions

We have previously synthesized glutaraldehyde-cross-linked polymerized human Hb (PolyhHbs) with either low (T-state) or high (R-state) O₂ affinity. In this study, we demonstrated that molar mixtures of T-state and R-state PolyhHbs can yield HBOCs with tunable O₂ affinities. Additionally, O₂ transport simulations performed in this study suggest that mixtures of PolyhHbs with T-state molar fractions greater than 50% are able to oxygenate a hepatic HF bioreactor better than those with T-state PolyhHb molar fractions less than 50%. Furthermore, by decreasing the T-state PolyhHb molar fraction, the ratio of pericentral to perivenous oxygenation was computationally calculated to decrease by 50% with minimal formation of hypoxic zones.

Supporting information

S1 File. In depth computational model methods and parameters.

This file outlines the equations and parameters for the COMSOL model used to analyze oxygenation in a single hollow fiber contained in the bioreactor.

https://doi.org/10.1371/journal.pone.0185988.s001

(DOCX)

S1 Table. PolyhHb results.

Table containing the biophysical properties for each of the PolyhHbs synthesized in this study.

https://doi.org/10.1371/journal.pone.0185988.s002

(XLSX)

Acknowledgments

We acknowledge Dr. Christopher Hadad (Dept. of Chemistry and Biochemistry, The Ohio State University) for kindly allowing the use of his stopped-flow spectrophotometer, Dr. Robert J. Lee (College of Pharmacy, The Ohio State University) for permitting the use of his dynamic light scattering (DLS) spectrometer, and the Ohio State University Center for Chemical and Biophysical Dynamics for use of their transient UV/Vis flash photolysis system. We further acknowledge Marni Grevenow (Transfusion Services, Wexner Medical Center, The Ohio State University) for generously donating expired human RBC units. This work was supported by National Institutes of Health grants R56HL123015, R01HL126945 and R01EB021926.

References

1. Stamati K, Mudera V, Cheema U. Evolution of oxygen utilization in multicellular organisms and implications for cell signalling in tissue engineering. J Tissue Eng. SAGE PublicationsSage UK: London, England; 2011;2: 2041731411432365. pmid:22292107
- View Article
- PubMed/NCBI
- Google Scholar
2. Sullivan JP, Gordon JE, Palmer AF. Simulation of oxygen carrier mediated oxygen transport to C3A hepatoma cells housed within a hollow fiber bioreactor. Biotechnol Bioeng. 2006;93: 306–317. pmid:16161160
- View Article
- PubMed/NCBI
- Google Scholar
3. AABB, American Red Cross. Circular of information for the use of human blood and blood components. FDA-Center for Biologics Evaluation and Research; 2013. pp. 1–38.
- View Article
- Google Scholar
4. Moore EE. Blood substitutes: The future is now. J Am Coll Surg. 2003;196: 1–17. pmid:12517544
- View Article
- PubMed/NCBI
- Google Scholar
5. Whitaker B. Report of the United States Department of Health and Human Services: the 2009 National Blood Collection and Utilization Survey Report. Washington, DC: United States Department of Health and Human Services: Office of the Assistant Secretary for Health; 2011.
6. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: Benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004;70: 15–28. pmid:15339855
- View Article
- PubMed/NCBI
- Google Scholar
7. Buehler PW, Alayash AI. Redox biology of blood revisited: the role of red blood cells in maintaining circulatory reductive capacity. Antioxid Redox Signal. Mary Ann Liebert, Inc. 2 Madison Avenue Larchmont, NY 10538 USA; 2005;7: 1755–1760. pmid:16356136
- View Article
- PubMed/NCBI
- Google Scholar
8. Mozzarelli A, Bettati S. Chemistry and Biochemistry of Oxygen Therapeutics: From Transfusion to Artificial Blood [Internet]. Chemistry and Biochemistry of Oxygen Therapeutics: From Transfusion to Artificial Blood. Chichester, UK: John Wiley & Sons, Ltd; 2011. https://doi.org/10.1002/9781119975427
9. Olsen KW, Tarasov E. Crosslinked and Polymerized Hemoglobins as Potential Blood Substitutes. In: Mozzarelli A, Bettati S, editors. Chemistry and Biochemistry of Oxygen Therapeutics. John Wiley & Sons, Ltd; 2011. pp. 327–344. http://onlinelibrary.wiley.com/doi/10.1002/9781119975427.ch24/summary%0Ahttp://files/2245/summary.html
10. Rameez S, Banerjee U, Fontes J, Roth A, Palmer AF. Reactivity of polymersome encapsulated hemoglobin with physiologically important gaseous ligands: Oxygen, carbon monoxide, and nitric oxide. Macromolecules. 2012;45: 2385–2389. pmid:22865934
- View Article
- PubMed/NCBI
- Google Scholar
11. Rameez S, Guzman N, Banerjee U, Fontes J, Paulaitis ME, Palmer AF, et al. Encapsulation of hemoglobin inside liposomes surface conjugated with poly(ethylene glycol) attenuates their reactions with gaseous ligands and regulates nitric oxide dependent vasodilation. Biotechnol Prog. 2012;28: 636–645. pmid:22467599
- View Article
- PubMed/NCBI
- Google Scholar
12. Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E. Hemoglobin-vesicle, a cellular artificial oxygen carrier that fulfils the physiological roles of the red blood cell structure. In: Takahashi E, Bruley DF, editors. Advances in Experimental Medicine and Biology. Boston, MA: Springer US; 2010. pp. 433–438. pmid:20204826
- View Article
- PubMed/NCBI
- Google Scholar
13. Simoni J. Artificial oxygen carriers: Scientific and biotechnological points of view. Artif Organs. 2009;33: 92–96. pmid:19178451
- View Article
- PubMed/NCBI
- Google Scholar
14. Baek JH, Zhou Y, Harris DR, Schaer DJ, Palmer AF, Buehler PW. Down Selection of Polymerized Bovine Hemoglobins for Use as Oxygen Releasing Therapeutics in a Guinea Pig Model. Toxicol Sci. 2012;127: 567–581. pmid:22416071
- View Article
- PubMed/NCBI
- Google Scholar
15. Buehler PW, Zhou Y, Cabrales P, Jia Y, Sun G, Harris DR, et al. Synthesis, biophysical properties and pharmacokinetics of ultrahigh molecular weight tense and relaxed state polymerized bovine hemoglobins. Biomaterials. 2010;31: 3723–3735. pmid:20149433
- View Article
- PubMed/NCBI
- Google Scholar
16. Palmer AF, Sun G, Harris DR. The quaternary structure of tetrameric hemoglobin regulates the oxygen affinity of polymerized hemoglobin. Biotechnol Prog. 2009;25: 1803–1809. pmid:19725116
- View Article
- PubMed/NCBI
- Google Scholar
17. Zhang N, Jia Y, Chen G, Cabrales P, Palmer AF. Biophysical properties and oxygenation potential of high-molecular-weight glutaraldehyde-polymerized human hemoglobins maintained in the tense and relaxed quaternary states. Tissue Eng Part A. 2011;17: 927–940. pmid:20979534
- View Article
- PubMed/NCBI
- Google Scholar
18. Zhou Y, Jia Y, Buehler PW, Chen G, Cabrales P, Palmer AF. Synthesis, biophysical properties, and oxygenation potential of variable molecular weight glutaraldehyde-polymerized bovine hemoglobins with low and high oxygen affinity. Biotechnol Prog. 2011;27: 1172–1184. pmid:21584950
- View Article
- PubMed/NCBI
- Google Scholar
19. Kietzmann T. Metabolic zonation of the liver: The oxygen gradient revisited [Internet]. Redox Biology. 2017. pp. 622–630. pmid:28126520
- View Article
- PubMed/NCBI
- Google Scholar
20. Palmer AF, Sun G, Harris DR. Tangential flow filtration of hemoglobin. Biotechnol Prog. 2009;25: 189–199. pmid:19224583
- View Article
- PubMed/NCBI
- Google Scholar
21. Zhou Y. Synthesis and Biophysical Characterization of Polymerized Hemoglobin Dispersions of Varying Size and Oxygen Affinity as Potential Oxygen Carriers for use in Transfusion Medicine [Internet]. ProQuest Dissertations and Theses. The Ohio State University. 2011. http://search.proquest.com/docview/920005184?accountid=8359
22. Arifin DR, Palmer AF. Determination of Size Distribution and Encapsulation Efficiency of Liposome-Encapsulated Hemoglobin Blood Substitutes Using Asymmetric Flow Field-Flow Fractionation Coupled with Multi-Angle Static Light Scattering. Biotechnol Prog. 2003;19: 1798–1811. pmid:14656159
- View Article
- PubMed/NCBI
- Google Scholar
23. Hawk PB. Blood analysis. Hawk’s Physiol Chem 14th New York McGraw-Hill. 1965; 1090–9.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248–254. pmid:942051
- View Article
- PubMed/NCBI
- Google Scholar
25. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol. 1910;40: 4–7.
- View Article
- Google Scholar
26. Rameez S, Palmer AF. Simple method for preparing poly(ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: Physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO. Langmuir. 2011;27: 8829–8840. pmid:21678920
- View Article
- PubMed/NCBI
- Google Scholar
27. Olson JS, Foley EW, Maillett DH, Paster E V. Measurement of Rate Constants for Reactions of O<sub>2</sub>, CO, and NO with Hemoglobin. Hemoglobin Disorders. New Jersey: Humana Press; 2003. pp. 065–091. https://doi.org/10.1385/1-59259-373-9:065
28. Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: present and future. Gut. 2009;58: 1690–702. pmid:19923348
- View Article
- PubMed/NCBI
- Google Scholar
29. Chen G, Palmer AF. Hemoglobin-based oxygen carrier and convection enhanced oxygen transport in a hollow fiber bioreactor. Biotechnol Bioeng. 2009;102: 1603–1612. pmid:19072844
- View Article
- PubMed/NCBI
- Google Scholar
30. Xu H, Bjerneld EJ, Käll M, Börjesson L. Spectroscopy of Single Hemoglobin Molecules by Surface Enhanced Raman Scattering. Phys Rev Lett. 1999;83: 4357–4360.
- View Article
- Google Scholar
31. Poli de Figueiredo LF, Mathru M, Solanki D, Macdonald VW, Hess J, Kramer GC. Pulmonary Hypertension and Systemic Vasoconstriction May Offset the Benefits of Acellular Hemoglobin Blood Substitutes: J Trauma Inj Infect Crit Care. 1997;42: 847–856.
- View Article
- Google Scholar
32. Sakai H, Hara H, Yuasa M, Tsai AG, Takeoka S, Tsuchida E, et al. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol. 2000;279: H908–915. pmid:10993749
- View Article
- PubMed/NCBI
- Google Scholar
33. Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood. 2006;108: 3603–3610. pmid:16857991
- View Article
- PubMed/NCBI
- Google Scholar
34. Vajpayee N, Graham SS, Bem S. Basic Examination of Blood and Bone Marrow. Henry’s Clinical Diagnosis and Management by Laboratory Methods. Elsevier; 2011. pp. 509–535.
35. Napolitano LM. Hemoglobin-based Oxygen Carriers: First, Second or Third Generation? Human or Bovine? Where are we Now? Crit Care Clin. 2009;25: 279–301. pmid:19341909
- View Article
- PubMed/NCBI
- Google Scholar
36. Carmichael FJ, Ali AC, Campbell JA, Langlois SF, Biro GP, Willan AR, et al. A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med. 2000;28: 2283–2292. pmid:10921554
- View Article
- PubMed/NCBI
- Google Scholar
37. Palmer AF, Zhang N, Zhou Y, Harris DR, Cabrales P. Small-Volume Resuscitation From Hemorrhagic Shock Using High-Molecular-Weight Tense-State Polymerized Hemoglobins. J Trauma Inj Infect Crit Care. 2011;71: 798–807. pmid:21336190
- View Article
- PubMed/NCBI
- Google Scholar
38. Eaton WA, Henry ER, Hofrichter J, Mozzarelli A. Is cooperative oxygen binding by hemoglobin really understood? Nat Struct Biol. 1999;6: 351–358. pmid:10201404
- View Article
- PubMed/NCBI
- Google Scholar
39. Sawicki CA, Gibson QH. Properties of the T State of Human Oxyhemoglobin Studied by Laser Photolysis*. http://www.jbc.org/content/252/21/7538.full.pdf
40. Mathews AJ, Olson JS. Assignment of rate constants for O2 and CO binding to α and β subunits within R- and T-state human hemoglobin. Academic Press; 1994;232: 363–386.
- View Article
- Google Scholar
41. Duling BR. Microvascular Responses to Alterations in Oxygen Tension. Circ Res. 1972;31: 481–489. pmid:5075370
- View Article
- PubMed/NCBI
- Google Scholar
42. Harder DR, Narayanan J, Birks EK, Liard JF, Imig JD, Lombard JH, et al. Identification of a putative microvascular oxygen sensor. Circ Res. 1996;79: 54–61. pmid:8925569
- View Article
- PubMed/NCBI
- Google Scholar
43. Jackson WF. Arteriolar oxygen reactivity is inhibited by leukotriene antagonists. Am J Physiol—Hear Circ Physiol. 1989;257: H1565–H1572. Available: http://ajpheart.physiology.org/content/257/5/H1565%0Ahttp://files/2262/Jackson%20-%201989%20-%20Arteriolar%20oxygen%20reactivity%20is%20inhibited%20by%20leuko.pdf%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/2511767%0Ahttp://files/2264/H1565.html
- View Article
- Google Scholar
44. Erickson HP. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol Proced Online. 2009;11: 32–51. pmid:19495910
- View Article
- PubMed/NCBI
- Google Scholar
45. Boykins RA, Buehler PW, Jia Y, Venable R, Alayash AI. O-raffinose crosslinked hemoglobin lacks site-specific chemistry in the central cavity: Structural and functional consequences of ??93Cys modification. Proteins Struct Funct Genet. 2005;59: 840–855. pmid:15822103
- View Article
- PubMed/NCBI
- Google Scholar
46. Buehler PW, Boykins RA, Jia Y, Norris S, Freedberg DI, Alayash AI. Structural and functional characterization of glutaraldehyde-polymerized bovine hemoglobin and its isolated fractions. Anal Chem. 2005;77: 3466–3478. pmid:15924377
- View Article
- PubMed/NCBI
- Google Scholar
47. Jia Y, Ramasamy S, Wood F, Alayash AI, Rifkind JM. Cross-linking with O -raffinose lowers oxygen affinity and stabilizes haemoglobin in a non-cooperative T-state conformation. Biochem J. 2004;384: 367–375. pmid:15303971
- View Article
- PubMed/NCBI
- Google Scholar
48. Buehler Paul W., Boykins Robert A., Jia Yiping, Norris Scott, Freedberg Darón I. and, Alayash Abdu I.. Structural and Functional Characterization of Glutaraldehyde-Polymerized Bovine Hemoglobin and Its Isolated Fractions. American Chemical Society; 2005; pmid:15924377
- View Article
- PubMed/NCBI
- Google Scholar
49. Ali AA, Ali GS, Steinke JM, Shepherd AP. Co-Oximetry Interference by Hemoglobin-Based Blood Substitutes. Anesth Analg. 2001; 863–869. pmid:11273915
- View Article
- PubMed/NCBI
- Google Scholar
50. Day TK. Current development and use of hemoglobin-based oxygen-carrying (HBOC) solutions. J Vet Emerg Crit Care. Blackwell Publishing; 2003;13: 77–93.
- View Article
- Google Scholar
51. Allen JW, Bhatia SN. Formation of steady-state oxygen gradients in vitro: Application to liver zonation. Biotechnol Bioeng. 2003;82: 253–262. pmid:12599251
- View Article
- PubMed/NCBI
- Google Scholar
52. Lindros KO. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol. 1997;28: 191–196. pmid:9013193
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Stamati K, Mudera V, Cheema U. Evolution of oxygen utilization in multicellular organisms and implications for cell signalling in tissue engineering. J Tissue Eng. SAGE PublicationsSage UK: London, England; 2011;2: 2041731411432365. pmid:22292107
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Sullivan JP, Gordon JE, Palmer AF. Simulation of oxygen carrier mediated oxygen transport to C3A hepatoma cells housed within a hollow fiber bioreactor. Biotechnol Bioeng. 2006;93: 306–317. pmid:16161160
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. AABB, American Red Cross. Circular of information for the use of human blood and blood components. FDA-Center for Biologics Evaluation and Research; 2013. pp. 1–38.
View Article
Google Scholar

[10] View Article

[11] Google Scholar

[ref4] 4. Moore EE. Blood substitutes: The future is now. J Am Coll Surg. 2003;196: 1–17. pmid:12517544
View Article
PubMed/NCBI
Google Scholar

[13] View Article

[14] PubMed/NCBI

[15] Google Scholar

[ref5] 5. Whitaker B. Report of the United States Department of Health and Human Services: the 2009 National Blood Collection and Utilization Survey Report. Washington, DC: United States Department of Health and Human Services: Office of the Assistant Secretary for Health; 2011.

[ref6] 6. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: Benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004;70: 15–28. pmid:15339855
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref7] 7. Buehler PW, Alayash AI. Redox biology of blood revisited: the role of red blood cells in maintaining circulatory reductive capacity. Antioxid Redox Signal. Mary Ann Liebert, Inc. 2 Madison Avenue Larchmont, NY 10538 USA; 2005;7: 1755–1760. pmid:16356136
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref8] 8. Mozzarelli A, Bettati S. Chemistry and Biochemistry of Oxygen Therapeutics: From Transfusion to Artificial Blood [Internet]. Chemistry and Biochemistry of Oxygen Therapeutics: From Transfusion to Artificial Blood. Chichester, UK: John Wiley & Sons, Ltd; 2011. https://doi.org/10.1002/9781119975427

[ref9] 9. Olsen KW, Tarasov E. Crosslinked and Polymerized Hemoglobins as Potential Blood Substitutes. In: Mozzarelli A, Bettati S, editors. Chemistry and Biochemistry of Oxygen Therapeutics. John Wiley & Sons, Ltd; 2011. pp. 327–344. http://onlinelibrary.wiley.com/doi/10.1002/9781119975427.ch24/summary%0Ahttp://files/2245/summary.html

[ref10] 10. Rameez S, Banerjee U, Fontes J, Roth A, Palmer AF. Reactivity of polymersome encapsulated hemoglobin with physiologically important gaseous ligands: Oxygen, carbon monoxide, and nitric oxide. Macromolecules. 2012;45: 2385–2389. pmid:22865934
View Article
PubMed/NCBI
Google Scholar

[28] View Article

[29] PubMed/NCBI

[30] Google Scholar

[ref11] 11. Rameez S, Guzman N, Banerjee U, Fontes J, Paulaitis ME, Palmer AF, et al. Encapsulation of hemoglobin inside liposomes surface conjugated with poly(ethylene glycol) attenuates their reactions with gaseous ligands and regulates nitric oxide dependent vasodilation. Biotechnol Prog. 2012;28: 636–645. pmid:22467599
View Article
PubMed/NCBI
Google Scholar

[32] View Article

[33] PubMed/NCBI

[34] Google Scholar

[ref12] 12. Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E. Hemoglobin-vesicle, a cellular artificial oxygen carrier that fulfils the physiological roles of the red blood cell structure. In: Takahashi E, Bruley DF, editors. Advances in Experimental Medicine and Biology. Boston, MA: Springer US; 2010. pp. 433–438. pmid:20204826
View Article
PubMed/NCBI
Google Scholar

[36] View Article

[37] PubMed/NCBI

[38] Google Scholar

[ref13] 13. Simoni J. Artificial oxygen carriers: Scientific and biotechnological points of view. Artif Organs. 2009;33: 92–96. pmid:19178451
View Article
PubMed/NCBI
Google Scholar

[40] View Article

[41] PubMed/NCBI

[42] Google Scholar

[ref14] 14. Baek JH, Zhou Y, Harris DR, Schaer DJ, Palmer AF, Buehler PW. Down Selection of Polymerized Bovine Hemoglobins for Use as Oxygen Releasing Therapeutics in a Guinea Pig Model. Toxicol Sci. 2012;127: 567–581. pmid:22416071
View Article
PubMed/NCBI
Google Scholar

[44] View Article

[45] PubMed/NCBI

[46] Google Scholar

[ref15] 15. Buehler PW, Zhou Y, Cabrales P, Jia Y, Sun G, Harris DR, et al. Synthesis, biophysical properties and pharmacokinetics of ultrahigh molecular weight tense and relaxed state polymerized bovine hemoglobins. Biomaterials. 2010;31: 3723–3735. pmid:20149433
View Article
PubMed/NCBI
Google Scholar

[48] View Article

[49] PubMed/NCBI

[50] Google Scholar

[ref16] 16. Palmer AF, Sun G, Harris DR. The quaternary structure of tetrameric hemoglobin regulates the oxygen affinity of polymerized hemoglobin. Biotechnol Prog. 2009;25: 1803–1809. pmid:19725116
View Article
PubMed/NCBI
Google Scholar

[52] View Article

[53] PubMed/NCBI

[54] Google Scholar

[ref17] 17. Zhang N, Jia Y, Chen G, Cabrales P, Palmer AF. Biophysical properties and oxygenation potential of high-molecular-weight glutaraldehyde-polymerized human hemoglobins maintained in the tense and relaxed quaternary states. Tissue Eng Part A. 2011;17: 927–940. pmid:20979534
View Article
PubMed/NCBI
Google Scholar

[56] View Article

[57] PubMed/NCBI

[58] Google Scholar

[ref18] 18. Zhou Y, Jia Y, Buehler PW, Chen G, Cabrales P, Palmer AF. Synthesis, biophysical properties, and oxygenation potential of variable molecular weight glutaraldehyde-polymerized bovine hemoglobins with low and high oxygen affinity. Biotechnol Prog. 2011;27: 1172–1184. pmid:21584950
View Article
PubMed/NCBI
Google Scholar

[60] View Article

[61] PubMed/NCBI

[62] Google Scholar

[ref19] 19. Kietzmann T. Metabolic zonation of the liver: The oxygen gradient revisited [Internet]. Redox Biology. 2017. pp. 622–630. pmid:28126520
View Article
PubMed/NCBI
Google Scholar

[64] View Article

[65] PubMed/NCBI

[66] Google Scholar

[ref20] 20. Palmer AF, Sun G, Harris DR. Tangential flow filtration of hemoglobin. Biotechnol Prog. 2009;25: 189–199. pmid:19224583
View Article
PubMed/NCBI
Google Scholar

[68] View Article

[69] PubMed/NCBI

[70] Google Scholar

[ref21] 21. Zhou Y. Synthesis and Biophysical Characterization of Polymerized Hemoglobin Dispersions of Varying Size and Oxygen Affinity as Potential Oxygen Carriers for use in Transfusion Medicine [Internet]. ProQuest Dissertations and Theses. The Ohio State University. 2011. http://search.proquest.com/docview/920005184?accountid=8359

[ref22] 22. Arifin DR, Palmer AF. Determination of Size Distribution and Encapsulation Efficiency of Liposome-Encapsulated Hemoglobin Blood Substitutes Using Asymmetric Flow Field-Flow Fractionation Coupled with Multi-Angle Static Light Scattering. Biotechnol Prog. 2003;19: 1798–1811. pmid:14656159
View Article
PubMed/NCBI
Google Scholar

[73] View Article

[74] PubMed/NCBI

[75] Google Scholar

[ref23] 23. Hawk PB. Blood analysis. Hawk’s Physiol Chem 14th New York McGraw-Hill. 1965; 1090–9.

[ref24] 24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248–254. pmid:942051
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref25] 25. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol. 1910;40: 4–7.
View Article
Google Scholar

[82] View Article

[83] Google Scholar

[ref26] 26. Rameez S, Palmer AF. Simple method for preparing poly(ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: Physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO. Langmuir. 2011;27: 8829–8840. pmid:21678920
View Article
PubMed/NCBI
Google Scholar

[85] View Article

[86] PubMed/NCBI

[87] Google Scholar

[ref27] 27. Olson JS, Foley EW, Maillett DH, Paster E V. Measurement of Rate Constants for Reactions of O<sub>2</sub>, CO, and NO with Hemoglobin. Hemoglobin Disorders. New Jersey: Humana Press; 2003. pp. 065–091. https://doi.org/10.1385/1-59259-373-9:065

[ref28] 28. Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: present and future. Gut. 2009;58: 1690–702. pmid:19923348
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref29] 29. Chen G, Palmer AF. Hemoglobin-based oxygen carrier and convection enhanced oxygen transport in a hollow fiber bioreactor. Biotechnol Bioeng. 2009;102: 1603–1612. pmid:19072844
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref30] 30. Xu H, Bjerneld EJ, Käll M, Börjesson L. Spectroscopy of Single Hemoglobin Molecules by Surface Enhanced Raman Scattering. Phys Rev Lett. 1999;83: 4357–4360.
View Article
Google Scholar

[98] View Article

[99] Google Scholar

[ref31] 31. Poli de Figueiredo LF, Mathru M, Solanki D, Macdonald VW, Hess J, Kramer GC. Pulmonary Hypertension and Systemic Vasoconstriction May Offset the Benefits of Acellular Hemoglobin Blood Substitutes: J Trauma Inj Infect Crit Care. 1997;42: 847–856.
View Article
Google Scholar

[101] View Article

[102] Google Scholar

[ref32] 32. Sakai H, Hara H, Yuasa M, Tsai AG, Takeoka S, Tsuchida E, et al. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol. 2000;279: H908–915. pmid:10993749
View Article
PubMed/NCBI
Google Scholar

[104] View Article

[105] PubMed/NCBI

[106] Google Scholar

[ref33] 33. Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood. 2006;108: 3603–3610. pmid:16857991
View Article
PubMed/NCBI
Google Scholar

[108] View Article

[109] PubMed/NCBI

[110] Google Scholar

[ref34] 34. Vajpayee N, Graham SS, Bem S. Basic Examination of Blood and Bone Marrow. Henry’s Clinical Diagnosis and Management by Laboratory Methods. Elsevier; 2011. pp. 509–535.

[ref35] 35. Napolitano LM. Hemoglobin-based Oxygen Carriers: First, Second or Third Generation? Human or Bovine? Where are we Now? Crit Care Clin. 2009;25: 279–301. pmid:19341909
View Article
PubMed/NCBI
Google Scholar

[113] View Article

[114] PubMed/NCBI

[115] Google Scholar

[ref36] 36. Carmichael FJ, Ali AC, Campbell JA, Langlois SF, Biro GP, Willan AR, et al. A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med. 2000;28: 2283–2292. pmid:10921554
View Article
PubMed/NCBI
Google Scholar

[117] View Article

[118] PubMed/NCBI

[119] Google Scholar

[ref37] 37. Palmer AF, Zhang N, Zhou Y, Harris DR, Cabrales P. Small-Volume Resuscitation From Hemorrhagic Shock Using High-Molecular-Weight Tense-State Polymerized Hemoglobins. J Trauma Inj Infect Crit Care. 2011;71: 798–807. pmid:21336190
View Article
PubMed/NCBI
Google Scholar

[121] View Article

[122] PubMed/NCBI

[123] Google Scholar

[ref38] 38. Eaton WA, Henry ER, Hofrichter J, Mozzarelli A. Is cooperative oxygen binding by hemoglobin really understood? Nat Struct Biol. 1999;6: 351–358. pmid:10201404
View Article
PubMed/NCBI
Google Scholar

[125] View Article

[126] PubMed/NCBI

[127] Google Scholar

[ref39] 39. Sawicki CA, Gibson QH. Properties of the T State of Human Oxyhemoglobin Studied by Laser Photolysis*. http://www.jbc.org/content/252/21/7538.full.pdf

[ref40] 40. Mathews AJ, Olson JS. Assignment of rate constants for O2 and CO binding to α and β subunits within R- and T-state human hemoglobin. Academic Press; 1994;232: 363–386.
View Article
Google Scholar

[130] View Article

[131] Google Scholar

[ref41] 41. Duling BR. Microvascular Responses to Alterations in Oxygen Tension. Circ Res. 1972;31: 481–489. pmid:5075370
View Article
PubMed/NCBI
Google Scholar

[133] View Article

[134] PubMed/NCBI

[135] Google Scholar

[ref42] 42. Harder DR, Narayanan J, Birks EK, Liard JF, Imig JD, Lombard JH, et al. Identification of a putative microvascular oxygen sensor. Circ Res. 1996;79: 54–61. pmid:8925569
View Article
PubMed/NCBI
Google Scholar

[137] View Article

[138] PubMed/NCBI

[139] Google Scholar

[ref43] 43. Jackson WF. Arteriolar oxygen reactivity is inhibited by leukotriene antagonists. Am J Physiol—Hear Circ Physiol. 1989;257: H1565–H1572. Available: http://ajpheart.physiology.org/content/257/5/H1565%0Ahttp://files/2262/Jackson%20-%201989%20-%20Arteriolar%20oxygen%20reactivity%20is%20inhibited%20by%20leuko.pdf%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/2511767%0Ahttp://files/2264/H1565.html
View Article
Google Scholar

[141] View Article

[142] Google Scholar

[ref44] 44. Erickson HP. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol Proced Online. 2009;11: 32–51. pmid:19495910
View Article
PubMed/NCBI
Google Scholar

[144] View Article

[145] PubMed/NCBI

[146] Google Scholar

[ref45] 45. Boykins RA, Buehler PW, Jia Y, Venable R, Alayash AI. O-raffinose crosslinked hemoglobin lacks site-specific chemistry in the central cavity: Structural and functional consequences of ??93Cys modification. Proteins Struct Funct Genet. 2005;59: 840–855. pmid:15822103
View Article
PubMed/NCBI
Google Scholar

[148] View Article

[149] PubMed/NCBI

[150] Google Scholar

[ref46] 46. Buehler PW, Boykins RA, Jia Y, Norris S, Freedberg DI, Alayash AI. Structural and functional characterization of glutaraldehyde-polymerized bovine hemoglobin and its isolated fractions. Anal Chem. 2005;77: 3466–3478. pmid:15924377
View Article
PubMed/NCBI
Google Scholar

[152] View Article

[153] PubMed/NCBI

[154] Google Scholar

[ref47] 47. Jia Y, Ramasamy S, Wood F, Alayash AI, Rifkind JM. Cross-linking with O -raffinose lowers oxygen affinity and stabilizes haemoglobin in a non-cooperative T-state conformation. Biochem J. 2004;384: 367–375. pmid:15303971
View Article
PubMed/NCBI
Google Scholar

[156] View Article

[157] PubMed/NCBI

[158] Google Scholar

[ref48] 48. Buehler Paul W., Boykins Robert A., Jia Yiping, Norris Scott, Freedberg Darón I. and, Alayash Abdu I.. Structural and Functional Characterization of Glutaraldehyde-Polymerized Bovine Hemoglobin and Its Isolated Fractions. American Chemical Society; 2005; pmid:15924377
View Article
PubMed/NCBI
Google Scholar

[160] View Article

[161] PubMed/NCBI

[162] Google Scholar

[ref49] 49. Ali AA, Ali GS, Steinke JM, Shepherd AP. Co-Oximetry Interference by Hemoglobin-Based Blood Substitutes. Anesth Analg. 2001; 863–869. pmid:11273915
View Article
PubMed/NCBI
Google Scholar

[164] View Article

[165] PubMed/NCBI

[166] Google Scholar

[ref50] 50. Day TK. Current development and use of hemoglobin-based oxygen-carrying (HBOC) solutions. J Vet Emerg Crit Care. Blackwell Publishing; 2003;13: 77–93.
View Article
Google Scholar

[168] View Article

[169] Google Scholar

[ref51] 51. Allen JW, Bhatia SN. Formation of steady-state oxygen gradients in vitro: Application to liver zonation. Biotechnol Bioeng. 2003;82: 253–262. pmid:12599251
View Article
PubMed/NCBI
Google Scholar

[171] View Article

[172] PubMed/NCBI

[173] Google Scholar

[ref52] 52. Lindros KO. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol. 1997;28: 191–196. pmid:9013193
View Article
PubMed/NCBI
Google Scholar

[175] View Article

[176] PubMed/NCBI

[177] Google Scholar

Figures

Abstract

Introduction

Materials and methods

Materials

Hb purification

Synthesis of PolyhHb

Diafiltration of PolyhHb

Preparation of T- and R-State PolyhHb mixtures

Hydrodynamic diameter of PolyhHb

Methemoglobin level and protein concentration of hHb/PolyhHb

O2–hHb/PolyhHb equilibria measurements

Rapid kinetic measurements of hHb/PolyhHb solutions

Computational methods

Results and discussion

PolyhHb synthesis and characterization

Hydrodynamic diameter of PolyhHb

MetHb level and protein concentration of PolyhHb

O2–hHb/PolyhHb equilibria

Rapid kinetic measurements of hHb/PolyhHb solutions

Reactions with O2

Reactions with CO

Reactions with NO

Comparison to commercial HBOCS

Computational results

Conclusions

Supporting information

S1 File. In depth computational model methods and parameters.

S1 Table. PolyhHb results.

Acknowledgments

References

O₂–hHb/PolyhHb equilibria measurements

O₂–hHb/PolyhHb equilibria

Reactions with O₂